Live from the NIH registry
Studies recruiting near Flint right now
Top 25 of 169 recruiting studies, sorted by proximity — each links to its official registry page
Secukinumab Open Label Roll-over Extension Protocol
Autoimmunity, Inflammation
Phase 4
Interventional 1,000 participants sought
Ahmed Arif Medical Research Center — Grand Blanc, Michigan (7.3 mi)
· Sponsor: Novartis Pharmaceuticals
A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)
Relapsing Multiple Sclerosis, Multiple Sclerosis
N/A
Observational 2,000 participants sought
TG Therapeutics Investigational Trial Site — Owosso, Michigan (24.5 mi)
· Sponsor: TG Therapeutics, Inc.
C-Brace Prospective Registry
Pareses, Lower Extremity
N/A
Observational 250 participants sought
Wright & Filippis x Ottobock.care — Flint, Michigan (0.8 mi)
· Sponsor: Otto Bock Healthcare Products GmbH
Testing the Addition of Total Ablative Therapy to Usual Systemic Therapy Treatment for Limited Metastatic Colorectal Cancer, ERASur Trial
Metastatic Colorectal Adenocarcinoma, Stage IV Colorectal Cancer AJCC v8
Phase 2
Interventional 146 participants sought
Genesys Hurley Cancer Institute — Flint, Michigan (0.8 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
NV PSR INSPIRE-A Pipeline™ Vantage Post Approval Study
Intracranial Aneurysm
N/A
Observational 118 participants sought
McLaren Healthcare — Flint, Michigan (0.8 mi)
· Sponsor: Medtronic Neurovascular Clinical Affairs
A Study to Assess the Efficacy, Safety, and Tolerability of IMVT-1402 as Treatment for Adult Participants With Graves' Disease
Graves' Disease
Phase 2
Interventional 240 participants sought
Site Number - 1069 — Flint, Michigan (0.8 mi)
· Sponsor: Immunovant Sciences GmbH
Proton Radiation for Unresectable, Borderline Resectable, or Medically Inoperable Carcinoma of the Pancreas
Pancreatic Cancer
Phase 2
Interventional 60 participants sought
McLaren Proton Therapy Center — Flint, Michigan (0.8 mi)
· Sponsor: Proton Collaborative Group
Scaling up Maternal Health Equity Best Practices
Maternal Mortality Disparities, Maternal Morbidity Disparities
N/A
Interventional 600 participants sought
Michigan State University on behalf on 12 Michigan counties — Flint, Michigan (0.8 mi)
· Sponsor: Michigan State University
A Study of the Effect of ZT-01 on Night-time Hypoglycemia in Type 1 Diabetes
Type 1 Diabetes Mellitus With Hypoglycemia
Phase 2
Interventional 186 participants sought
Elite Research Center — Flint, Michigan (0.8 mi)
· Sponsor: Zucara Therapeutics Inc.
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
Breast Cancer
Phase 3
Interventional 3,960 participants sought
Cancer Hematology Centers - Flint — Flint, Michigan (0.8 mi)
· Sponsor: NRG Oncology
Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patients With Head and Neck Cancer
Multiple conditions
Phase 2
Interventional 98 participants sought
McLaren Cancer Institute-Flint — Flint, Michigan (0.8 mi)
· Sponsor: NRG Oncology
A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary Disease
Moderate to Severe Chronic Obstructive Pulmonary Disease
Phase 2, Phase 3
Interventional 1,156 participants sought
AA Medical Research Center — Flint, Michigan (0.8 mi)
· Sponsor: Pfizer
Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin
Heart Failure
Phase 3
Interventional 11,300 participants sought
Research Site — Flint, Michigan (0.8 mi)
· Sponsor: AstraZeneca
This Study is a Non-interventional Disease Registry of Adolescent and Adult Patients With Atopic Dermatitis Who Initiate or Switch Any Systemic Treatment
Atopic Dermatitis
N/A
Observational 1,000 participants sought
Michigan Dermatology Institute - Waterford- Site Number : 8400013 — Waterford, Michigan (26.9 mi)
· Sponsor: Sanofi
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
Lymphoma, Non-Hodgkin, Multiple Myeloma
Phase 2
Interventional 4,200 participants sought
Genesys Hurley Cancer Institute — Flint, Michigan (0.8 mi)
· Sponsor: American Society of Clinical Oncology
Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL), EVOLVE CLL/SLL Study
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
Phase 3
Interventional 247 participants sought
Cancer Hematology Centers - Flint — Flint, Michigan (0.8 mi)
· Sponsor: National Cancer Institute (NCI)
A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have Not Taken Biologic Medicines
Psoriatic Arthritis
Phase 3
Interventional 1,088 participants sought
Michigan Rheumatology Group, P.C. - Grand Blanc Office — Grand Blanc, Michigan (7.3 mi)
· Sponsor: Takeda
A Ph II Study of the TheraBionic P1 Device in Subjects With Hormone Positive Breast Cancer
HER2-negative Breast Cancer, Hormone Receptor Positive Tumor
N/A
Interventional 82 participants sought
Karmanos Cancer Institute at McLaren Flint — Flint, Michigan (0.8 mi)
· Sponsor: Barbara Ann Karmanos Cancer Institute
Testing the Addition of MEDI4736 (Durvalumab) to Chemotherapy Before Surgery for Patients With High-Grade Upper Urinary Tract Cancer
Renal Pelvis and Ureter Urothelial Carcinoma
Phase 2, Phase 3
Interventional 131 participants sought
Cancer Hematology Centers - Flint — Flint, Michigan (0.8 mi)
· Sponsor: National Cancer Institute (NCI)
Immune Checkpoint Inhibitor Toxicity Risk Prediction in Solid Tumors
Malignant Solid Neoplasm
N/A
Observational 2,062 participants sought
Cancer Hematology Centers - Flint — Flint, Michigan (0.8 mi)
· Sponsor: SWOG Cancer Research Network
Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)
Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic/Myeloproliferative Neoplasm
Phase 2
Interventional 335 participants sought
Cancer Hematology Centers - Flint — Flint, Michigan (0.8 mi)
· Sponsor: National Cancer Institute (NCI)
TheraBionic P1 Device in Subjects With Advanced Hepatocellular Carcinoma
Hepatocellular Carcinoma Recurrent
N/A
Interventional 198 participants sought
Karmanos Cancer Institute at McLaren Flint — Flint, Michigan (0.8 mi)
· Sponsor: Barbara Ann Karmanos Cancer Institute
Testing Osimertinib as a Treatment for Lung Cancers With an EGFR Exon 20 Change
Advanced Lung Non-Small Cell Carcinoma, Recurrent Lung Non-Small Cell Carcinoma
Phase 2
Interventional 46 participants sought
Cancer Hematology Centers - Flint — Flint, Michigan (0.8 mi)
· Sponsor: National Cancer Institute (NCI)
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 2a Study With an Open-Label Extension Evaluating the Efficacy and Safety of VENT-03 in Adult Participants With Active Cutaneous Lupus Erythematosus With or Without Systemic Lupus Erythematosus
Cutaneous Lupus Erythematosus (CLE), Systemic Lupus Erythematosus
Phase 2
Interventional 24 participants sought
Investigative Site — Flint, Michigan (0.8 mi)
· Sponsor: Ventus Therapeutics U.S., Inc.
A Study to Investigate Abdominal Symptoms With Camlipixant Compared With Placebo in Adults With Irritable Bowel Syndrome - Diarrhea (IBS-D) and Irritable Bowel Syndrome - Mixed (IBS-M)
Irritable Bowel Syndrome
Phase 2
Interventional 420 participants sought
GSK Investigational Site — Flint, Michigan (0.8 mi)
· Sponsor: GlaxoSmithKline